Nitschkowski, D.* et al. SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLC. Br. J. Cancer, DOI: 10.1038/s41416-025-02970-1 (2025)
Wang, J. et al. Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer. Br. J. Cancer 130, 1036-1045 (2024)
Hvidtfeldt, U.A.* et al. Long-term air pollution exposure and malignant intracranial tumours of the central nervous system: A pooled analysis of six European cohorts. Br. J. Cancer 129, 656-664 (2023)
Lorenzini, T.* et al. Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy. Br. J. Cancer 129, 696-705 (2023)
Pisula, J.I.* et al. Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks. Br. J. Cancer 128, 1369-1376 (2023)
Chen, J.* et al. Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: The ELAPSE project. Br. J. Cancer 126, 1499-1507 (2022)
Flach, S.* et al. Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma. Br. J. Cancer 126, 1186–1195 (2022)
Mukama, T.* et al. Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer. Br. J. Cancer (2022)
Seifert, M.* et al. Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function. Br. J. Cancer 127, 2175-2185 (2022)
Jesinghaus, M.* et al. Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma. Br. J. Cancer 122, 835-846 (2020)
Jesinghaus, M.* et al. Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma. Br. J. Cancer 121, 1050-1057 (2019)
Summerer, I. et al. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br. J. Cancer 113, 76-82 (2015)
Malinowsky, K.* et al. Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer. Br. J. Cancer 110, 2081-2089 (2014)
Wyler, L.* et al. Brain metastasis in renal cancer patients: Metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. Br. J. Cancer 110, 686-694 (2014)
Enciso-Mora, V.* et al. Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br. J. Cancer 108, 2178-2185 (2013)
Falkenberg, N. et al. MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion. Br. J. Cancer 109, 2714-2723 (2013)
Gross, E.* et al. Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers. Br. J. Cancer 109, 2347-2355 (2013)
Rohrmann, S.* et al. Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br. J. Cancer 108, 708-714 (2013)
Slotta-Huspenina, J.* et al. A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas. Br. J. Cancer 109, 370-378 (2013)
Buck, K.* et al. Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. Br. J. Cancer 105, 1151-1157 (2011)
Aubele, M. et al. In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues. Br. J. Cancer 103, 663-667 (2010)
Mallett, S.* ; Timmer, A. ; Sauerbrei, W.* & Altman, D.G.* Reporting of prognostic studies of tumour markers: A review of published articles in relation to REMARK guidelines. Br. J. Cancer 102, 173-180 (2010)
Horsch, M. et al. Overexpressed vs mutated Kras in murine fibroblasts: A molecular phenotyping study. Br. J. Cancer 100, 656-662 (2009)
Stumpf, M.* et al. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: Relevance of clonal selection of T lymphocytes. Br. J. Cancer 101, 1513-1521 (2009)
Aubele, M. et al. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br. J. Cancer 99, 1089-1095 (2008)
Blechschmidt, K.* et al. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br. J. Cancer 98, 489-495 (2008)
Hennig, R.* et al. BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br. J. Cancer 99, 1064-1073 (2008)
Atmaca, A.* et al. Valproic acid (VPA) in patients with refractory advanced cancer: A dose escalating phase I clinical trial. Br. J. Cancer 97, 177-182 (2007)
Aubele, M. et al. PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br. J. Cancer 96, 801-807 (2007)
Baeuerle, P.A.* & Gires, O. EpCAM (CD326) finding its role in cancer. Br. J. Cancer 96, 417-423 (2007)
Ruf, P.* et al. Characterisation of the new EpCAM-specific antibody HO-3: Implications for trifunctional antibody immunotherapy of cancer. Br. J. Cancer 97, 315-321 (2007)
Unger, K. et al. RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH. Br. J. Cancer 94, 1472-1477 (2006)
Crispo, A.* et al. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br. J. Cancer 91, 1280-1286 (2004)
Kreuzer, M.* ; Gerken, M. ; Kreienbrock, L. ; Wellmann, J. & Wichmann, H.-E. Lung cancer in lifetime nonsmoking men : Results of a case-control study in Germany. Br. J. Cancer 84, 134-140 (2001)
Kreuzer, M. et al. Gender differences in lung cancer risk by smoking: A multicentre case-control study in Germany and Italy. Br. J. Cancer 82, 227-233 (2000)
Zeidler, R.* et al. The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumor cells. Br. J. Cancer 83, 261-266 (2000)
Jacob, P. et al. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br. J. Cancer 80, 1461-1469 (1999)
Eichholtz-Wirth, H. ; Reidel, G. & Hietel, B. Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content. Br. J. Cancer 67, 1001-1006 (1993)
Eichholtz-Wirth, H. ; Reidel, G.* & Hietel, B. Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content. Br. J. Cancer 67, 1001-1006 (1993)
Schultz-Hector, S. ; Begg, A.C. ; Hofland, I.D. ; Kummermehr, J.C. & Sund, M. Cell kinetic analysis of murine squamous cell carcinomas: A comparison of single versus double labelling using flow cytometry and immunohistochemistry. Br. J. Cancer 68, 1097-1103 (1993)
Wolf, D.A. ; Kohlhuber, F. ; Schulz, P. ; Fittler, F. & Eick, D. Transcriptional Down-regulation of c-myc in Human Prostate Carcinoma Cells by the Synthetic Androgen Mibolerone. Br. J. Cancer 65, 376-382 (1992)
Eichholtz-Wirth, H. & Hietel, B. The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro. Br. J. Cancer 54, 239-243 (1986)
Bryant, P.E. Effects of ara A and fresh medium on chromosome damage and DNA double-strand break repair in X-irradiated stationary cells. Br. J. Cancer 49, 61-65 (1984)
Frankenberg, D. ; Frankenberg-Schwager, M. & Harbich, R. Interpretation of the shape of survival curves in terms of induction and repair/misrepair of DNA double-strand breaks. Br. J. Cancer 49, 233-238 (1984)
Frankenberg-Schwager, M. ; Frankenberg, D. & Harbich, R. Repair of DNA double-strand breaks as a determinant of RBE of alpha particles. Br. J. Cancer 49, 169-173 (1984)
Siede, W. & Eckardt, F. Indications for an inducible component of error-prone DNA repair in yeast. Br. J. Cancer 49, 103-106 (1984)
Born, R. & Eichholtz-Wirth, H. Effect of different physiological conditions of the action of adriamycin on Chinese hamster cells in vitro. Br. J. Cancer 44, 241-246 (1981)